Melatonin: Nature's most versatile biological signal?
暂无分享,去创建一个
D. Cardinali | V. Srinivasan | B. Poeggeler | R. Hardeland | G. Maestroni | S R Pandi-Perumal | V Srinivasan | B Poeggeler | R Hardeland | D P Cardinali | G J M Maestroni | S. Pandi-Perumal | S. Pandi‑Perumal
[1] Opher Caspi,et al. Melatonin for the prevention and treatment of jet lag. , 2004, Alternative therapies in health and medicine.
[2] C. Shapiro,et al. A Randomized, Double-Blind, Placebo-Controlled Crossover Study of the Effect of Exogenous Melatonin on Delayed Sleep Phase Syndrome , 2001, Psychosomatic medicine.
[3] D. Cardinali,et al. Melatonin in Circadian Rhythm Sleep Disorders , 2006 .
[4] D. Cardinali,et al. The role of melatonin in immuno‐enhancement: potential application in cancer , 2006, International journal of experimental pathology.
[5] R. C. Hobbs. Steroid-induced fractures and bone loss in patients with asthma , 1984 .
[6] W. Pryor,et al. The reaction of melatonin with peroxynitrite: formation of melatonin radical cation and absence of stable nitrated products. , 1998, Biochemical and biophysical research communications.
[7] P. Ylöstalo,et al. Seasonal, menstrual and circadian secretions of melatonin, gonadotropins and prolactin in women. , 1988, Acta physiologica Scandinavica.
[8] D. Tan,et al. Melatonin as an antioxidant: physiology versus pharmacology , 2005, Journal of pineal research.
[9] V. Srinivasan,et al. URINARY MELATONIN IN DEPRESSION , 1983, Indian journal of psychiatry.
[10] R. Kelly,et al. N-acetyl-5-methoxy kynurenamine, a brain metabolite of melatonin, is a potent inhibitor of prostaglandin biosynthesis. , 1984, Biochemical and biophysical research communications.
[11] D. Kunz,et al. Melatonin treatment of day-night rhythm disturbances and sundowning in Alzheimer disease: an open-label pilot study using actigraphy. , 2004, Journal of clinical psychopharmacology.
[12] M. Aktoz,et al. Decreased nocturnal synthesis of melatonin in patients with coronary artery disease. , 2003, International journal of cardiology.
[13] R. Reiter,et al. Melatonin stimulates brain glutathione peroxidase activity , 1995, Neurochemistry International.
[14] G. Migliorati,et al. Chrono-neuroendocrinological aspects of physiological aging and senile dementia. , 1994, Chronobiologia.
[15] M. Okawa,et al. SUPPLEMENTARY ADMINISTRATION OF ARTIFICIAL BRIGHT LIGHT AND MELATONIN AS POTENT TREATMENT FOR DISORGANIZED CIRCADIAN REST-ACTIVITY AND DYSFUNCTIONAL AUTONOMIC AND NEUROENDOCRINE SYSTEMS IN INSTITUTIONALIZED DEMENTED ELDERLY PERSONS , 2000, Chronobiology international.
[16] H. Manev,et al. Early upregulation of hippocampal 5-lipoxygenase following systemic administration of kainate to rats. , 1998, Restorative neurology and neuroscience.
[17] M. Dubocovich,et al. Melatonin desensitizes endogenous MT2 melatonin receptors in the rat suprachiasmatic nucleus: relevance for defining the periods of sensitivity of the mammalian circadian clock to melatonin , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[18] M. Migaud,et al. Melatonin and seasonal reproduction: understanding the neuroendocrine mechanisms using the sheep as a model. , 2002, Reproduction (Cambridge, England) Supplement.
[19] G. Maestroni. The immunotherapeutic potential of melatonin , 2001, Expert opinion on investigational drugs.
[20] A. Matsumoto,et al. Daily melatonin administration at middle age suppresses male rat visceral fat, plasma leptin, and plasma insulin to youthful levels. , 1999, Endocrinology.
[21] A. Lewy,et al. Melatonin shifts human circadian rhythms according to a phase-response curve. , 1992, Chronobiology international.
[22] L. Raisz,et al. Glucocorticoid-induced osteoporosis. , 1994, Rheumatic diseases clinics of North America.
[23] R. Hardeland,et al. Melatonin, a potent agent in antioxidative defense: Actions as a natural food constituent, gastrointestinal factor, drug and prodrug , 2005, Nutrition & metabolism.
[24] R. Reiter,et al. Melatonin and its derivatives cyclic 3‐hydroxymelatonin, N1‐acetyl‐N2‐formyl‐5‐methoxykynuramine and 6‐methoxymelatonin reduce oxidative DNA damage induced by Fenton reagents , 2003 .
[25] R. Reiter,et al. N1‐acetyl‐N2‐formyl‐5‐methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[26] T. Yamada,et al. Role of Serotonin for Scoliotic Deformity in Pinealectomized Chicken , 1997, Spine.
[27] V. Srinivasan. Melatonin, biological rhythm disorders and phototherapy. , 1997, Indian journal of physiology and pharmacology.
[28] David R Kaplan,et al. Neurotrophin signal transduction in the nervous system , 2000, Current Opinion in Neurobiology.
[29] R. Silman. Melatonin and the human gonadotrophin-releasing hormone pulse generator. , 1991, The Journal of endocrinology.
[30] R. Reiter,et al. Antioxidant properties of the melatonin metabolite N1-acetyl-5-methoxykynuramine (AMK): scavenging of free radicals and prevention of protein destruction , 2003, Redox report : communications in free radical research.
[31] R. Reiter,et al. Physiological concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum. , 1994, Life sciences.
[32] N. Raikhlin,et al. Melatonin and enterochromaffine cells. , 1976, Acta histochemica.
[33] R. Reiter. The pineal and its hormones in the control of reproduction in mammals. , 1980, Endocrine reviews.
[34] C. P. Maurizi. Alzheimer's disease: roles for mitochondrial damage, the hydroxyl radical, and cerebrospinal fluid deficiency of melatonin. , 2001, Medical hypotheses.
[35] D. Blask,et al. Putting cancer to sleep at night , 2005, Endocrine.
[36] S. Mccormick,et al. Effects of melatonin, its precursors and derivatives on the growth of cultured human uveal melanoma cells , 1998, Melanoma research.
[37] L. Wetterberg,et al. Serum melatonin in relation to clinical variables in patients with major depressive disorder and a hypothesis of a low melatonin syndrome , 1985, Acta psychiatrica Scandinavica.
[38] R. Hardeland. Melatonin: Multiple Functions in Signaling and Protection , 1997 .
[39] R. Reiter,et al. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species , 2007, Cell Biochemistry and Biophysics.
[40] M. Akbar,et al. Melatonin: an endogenous negative modulator of 12-lipoxygenation in the rat pineal gland. , 1999, The Biochemical journal.
[41] R. Reiter,et al. Mechanistic and comparative studies of melatonin and classic antioxidants in terms of their interactions with the ABTS cation radical , 2003, Journal of pineal research.
[42] Vanesa Martín,et al. Regulation of antioxidant enzymes: a significant role for melatonin , 2004, Journal of pineal research.
[43] K. Kugiyama,et al. Acute effects of melatonin administration on cardiovascular autonomic regulation in healthy men. , 2001, American heart journal.
[44] D. Cardinali,et al. Effect of melatonin on bone metabolism in ovariectomized rats. , 2001, Life sciences.
[45] A. Jouvet,et al. Evidence for tryptophan hydroxylase and hydroxy-indol-O-methyl-transferase mRNAs in human blood platelets. , 1997, Life sciences.
[46] Glenna A Dowling,et al. Melatonin for sleep disturbances in Parkinson's disease. , 2005, Sleep medicine.
[47] D. Cardinali,et al. Gender‐related differences in urinary 6‐sulfatoxymelatonin levels in obese pubertal individuals , 2006, Journal of pineal research.
[48] R. Reiter,et al. A review of the multiple actions of melatonin on the immune system , 2005, Endocrine.
[49] R. Reiter,et al. DNA oxidatively damaged by chromium(III) and H(2)O(2) is protected by the antioxidants melatonin, N(1)-acetyl-N(2)-formyl-5-methoxykynuramine, resveratrol and uric acid. , 2001, The international journal of biochemistry & cell biology.
[50] D. Pozo,et al. The use of melatonin as a vaccine agent. , 2005, Vaccine.
[51] John Trinder,et al. Sick and tired: does sleep have a vital role in the immune system? , 2004, Nature Reviews Immunology.
[52] Josep M. Guerrero,et al. High‐affinity binding of melatonin by human circulating T lymphocytes (CD4+) , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[53] D. Kripke,et al. Mortality associated with sleep duration and insomnia. , 2002, Archives of general psychiatry.
[54] S. Endo,et al. Double blind study of melatonin effects on the sleep-wake rhythm, cognitive and non-cognitive functions in Alzheimer type dementia. , 2003, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.
[55] Kiyofumi Yamada,et al. Mitochondrial dysfunction, endoplasmic reticulum stress, and apoptosis in Alzheimer's disease. , 2005, Journal of pharmacological sciences.
[56] Josep M. Guerrero,et al. Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role as intracrine, autocrine, and/or paracrine substance , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[57] V. Srinivasan. Melatonin oxidative stress and neurodegenerative diseases. , 2002, Indian journal of experimental biology.
[58] V. Anisimov,et al. Melatonin and colon carcinogenesis: I. Inhibitory effect of melatonin on development of intestinal tumors induced by 1,2-dimethylhydrazine in rats. , 1997, Carcinogenesis.
[59] D. Cardinali,et al. Future of melatonin as a therapeutic agent. , 2002, Neuro endocrinology letters.
[60] R. Reiter,et al. Rhythms of glutathione peroxidase and glutathione reductase in brain of chick and their inhibition by light , 1998, Neurochemistry International.
[61] A Lewinski,et al. Anticarcinogenic actions of melatonin which involve antioxidative processes: comparison with other antioxidants. , 2001, The international journal of biochemistry & cell biology.
[62] Koji Abe,et al. Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease , 2003, Journal of neurochemistry.
[63] G. Bubenik. REVIEW: Gastrointestinal Melatonin: Localization, Function, and Clinical Relevance , 2002, Digestive Diseases and Sciences.
[64] Valter Tucci,et al. Melatonin, circadian rhythms, and sleep , 2003, Current treatment options in neurology.
[65] R. Reiter,et al. The significance of the metabolism of the neurohormone melatonin: Antioxidative protection and formation of bioactive substances , 1993, Neuroscience & Biobehavioral Reviews.
[66] K. Schulmeister,et al. Melatonin and cancer risk: does light at night compromise physiologic cancer protection by lowering serum melatonin levels? , 2004, British Journal of Cancer.
[67] J. Macher,et al. [Pilot study comparing in blind the therapeutic effect of two doses of agomelatine, melatoninergic agonist and selective 5HT2C receptors antagonist, in the treatment of major depressive disorders]. , 2002, L'Encephale.
[68] L. Amzel,et al. Structures of mammalian cytosolic quinone reductases. , 2000, Free radical biology & medicine.
[69] R. Nelson,et al. Melatonin receptor (MT1) knockout mice display depression-like behaviors and deficits in sensorimotor gating , 2006, Brain Research Bulletin.
[70] K J Petrie,et al. Melatonin for the prevention and treatment of jet lag. , 2002, The Cochrane database of systematic reviews.
[71] A. Holen,et al. The effects of long meditation on plasma melatonin and blood serotonin. , 2004, Medical science monitor : international medical journal of experimental and clinical research.
[72] S. Fahn,et al. The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it , 1992, Annals of neurology.
[73] T. Takahashi,et al. Effect of 3 mg melatonin on jet lag syndrome in an 8‐h eastward flight , 2000, Psychiatry and clinical neurosciences.
[74] A. Cagnacci,et al. Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men. , 1999, The American journal of cardiology.
[75] M. Menaker,et al. The clock in the mouse retina: melatonin synthesis and photoreceptor degeneration , 1998, Brain Research.
[76] J. Barrett,et al. The oncostatic action of melatonin in an ovarian carcinoma cell line , 1999, Journal of pineal research.
[77] L. Carlson,et al. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients , 2004, Psychoneuroendocrinology.
[78] G. Maestroni,et al. Evidence for melatonin synthesis in mouse and human bone marrow cells , 2000, Journal of pineal research.
[79] D. Swaab,et al. Senescence, sleep, and circadian rhythms , 2002, Ageing Research Reviews.
[80] O. Nosjean,et al. Identification of the Melatonin-binding SiteMT 3 as the Quinone Reductase 2* , 2000, The Journal of Biological Chemistry.
[81] S. Markey,et al. Antidepressants reduce whole-body norepinephrine turnover while enhancing 6-hydroxymelatonin output. , 1988, Archives of general psychiatry.
[82] L. Tamarkin,et al. Melatonin: a coordinating signal for mammalian reproduction? , 1985, Science.
[83] J. Axelrod. The pineal gland: a neurochemical transducer. , 1974, Science.
[84] S. Checkley,et al. The Effect of Desipramine upon Melatonin and Cortisol Secretion in Depressed and Normal Subjects , 1985, British Journal of Psychiatry.
[85] C. Carlberg. Gene Regulation by Melatonin , 2000, Annals of the New York Academy of Sciences.
[86] E. Heist,et al. Neuroendocrine aspects of primary endogenous depression. XI. Serum melatonin measures in patients and matched control subjects. , 1992, Archives of general psychiatry.
[87] R. Reiter,et al. Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages , 2005, Journal of Neuroimmunology.
[88] Zheng Feng,et al. Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer's disease , 2004, Journal of pineal research.
[89] D. Klein. The 2004 Aschoff/Pittendrigh Lecture: Theory of the Origin of the Pineal Gland— A Tale of Conflict and Resolution , 2004, Journal of biological rhythms.
[90] R. Hardeland,et al. Oxidation of melatonin by carbonate radicals and chemiluminescence emitted during pyrrole ring cleavage , 2003, Journal of pineal research.
[91] H. Manev,et al. Circadian expression of pineal 5‐lipoxygenase mRNA , 1998, Neuroreport.
[92] D. Cardinali,et al. Metabolism of serotonin by the rat retina in vitro , 1971, Journal of neurochemistry.
[93] M. Ansseau,et al. Serum melatonin and urinary 6-sulfatoxymelatonin in major depression , 2004, Psychoneuroendocrinology.
[94] Xiaochao Ma,et al. METABOLISM OF MELATONIN BY HUMAN CYTOCHROMES P450 , 2005, Drug Metabolism and Disposition.
[95] Sato Honma,et al. Melatonin induces γ-glutamylcysteine synthetase mediated by activator protein-1 in human vascular endothelial cells , 1999 .
[96] J. Bruce,et al. Human pineal physiology and functional significance of melatonin , 2004, Frontiers in Neuroendocrinology.
[97] W. Johnson,et al. Melatonin, Sleep, and Shift Work Adaptation , 2005, Journal of occupational and environmental medicine.
[98] D. Boivin. Disturbances of Hormonal Circadian Rhythms in Shift Workers , 2006 .
[99] D. Cardinali,et al. Melatonin increases oestradiol‐induced bone formation in ovariectomized rats , 2003, Journal of pineal research.
[100] O. Pignataro,et al. Direct effect of melatonin on Syrian hamster testes: melatonin subtype 1a receptors, inhibition of androgen production, and interaction with the local corticotropin-releasing hormone system. , 2005, Endocrinology.
[101] D. Cardinali,et al. A multifactorial approach employing melatonin to accelerate resynchronization of sleep–wake cycle after a 12 time‐zone westerly transmeridian flight in elite soccer athletes , 2002, Journal of pineal research.
[102] J. Atkinson,et al. Melatonin improves cerebral circulation security margin in rats. , 1998, American journal of physiology. Heart and circulatory physiology.
[103] J. Glass,et al. A brain site for the antigonadal action of melatonin in the white-footed mouse (Peromyscus leucopus): involvement of the immunoreactive GnRH neuronal system. , 1987, Neuroendocrinology.
[104] R. Hardeland,et al. Non‐vertebrate melatonin , 2003, Journal of pineal research.
[105] F. Scheer,et al. Daily Nighttime Melatonin Reduces Blood Pressure in Male Patients With Essential Hypertension , 2004, Hypertension.
[106] H. Romijn. The pineal, a tranquillizing organ? , 1978, Life sciences.
[107] J. Nurnberger,et al. Effects of indirect light and propranolol on melatonin levels in normal human subjects , 1998, Psychiatry Research.
[108] R. Wurtman,et al. Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[109] Wen‐lang Lin,et al. Melatonin Promotes Osteoblast Differentiation and Bone Formation* , 1999, The Journal of Biological Chemistry.
[110] Josephine Arendt,et al. Melatonin-induced temperature suppression and its acute phase-shifting effects correlate in a dose-dependent manner in humans , 1995, Brain Research.
[111] B. Lukert. Glucocorticoid‐Induced Osteoporosis , 1992, Rheumatic diseases clinics of North America.
[112] B. Ishizuka,et al. Differential growth inhibitory effect of melatonin on two endometrial cancer cell lines , 2000, Journal of pineal research.
[113] D. Hu,et al. Melatonin inhibits growth of cultured human uveal melanoma cells , 1997, Melanoma research.
[114] F. Scheer. Potential use of melatonin as adjunct antihypertensive therapy. , 2005, American journal of hypertension.
[115] I. Macháčková,et al. Melatonin in higher plants: occurrence and possible functions , 2005, Journal of pineal research.
[116] R. Reiter,et al. The melatonin rhythm: both a clock and a calendar , 1993, Experientia.
[117] Zheng Feng,et al. Early melatonin supplementation alleviates oxidative stress in a transgenic mouse model of Alzheimer's disease. , 2006, Free radical biology & medicine.
[118] M. Dubocovich,et al. Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. , 2005, Cancer research.
[119] M. Schemper,et al. Serum melatonin in central precocious puberty is lower than in age-matched prepubertal children. , 1991, The Journal of clinical endocrinology and metabolism.
[120] D. Cardinali,et al. Melatonin and sleep in aging population , 2005, Experimental Gerontology.
[121] D. Cardinali. Nuclear receptor estrogen complex in the pineal gland. Modulation by sympathetic nerves. , 1977, Neuroendocrinology.
[122] D. Cardinali,et al. Does melatonin play a disease-promoting role in rheumatoid arthritis? , 2005, Journal of Neuroimmunology.
[123] D. Shapiro. Overview: clinical and physiological comparison of meditation with other self-control strategies. , 1982, The American journal of psychiatry.
[124] Josep M. Guerrero,et al. Melatonin reduces nitric oxide synthase activity in rat hypothalamus , 1996, Journal of pineal research.
[125] C. Eastman,et al. How to Trick Mother Nature into Letting You Fly Around or Stay Up All Night , 2005, Journal of biological rhythms.
[126] G. Tosini,et al. Localization of Aa-nat mRNA in the rat retina by fluorescence in situ hybridization and laser capture microdissection , 2004, Cell and Tissue Research.
[127] C. Viguié,et al. Importance of Photoperiodic Signal Quality to Entrainment of the Circannual Reproductive Rhythm of the Ewe1 , 2000, Biology of reproduction.
[128] K. Kolaja,et al. The role of oxidative stress in chemical carcinogenesis. , 1998, Environmental health perspectives.
[129] P. Lavie. Melatonin: Role in Gating Nocturnal Rise in Sleep Propensity , 1997, Journal of biological rhythms.
[130] D. Dijk,et al. Melatonin and the Circadian Regulation of Sleep Initiation, Consolidation, Structure, and the Sleep EEG , 1997, Journal of biological rhythms.
[131] A. Matsumoto,et al. Daily Melatonin Administration at Middle Age Suppresses Male Rate Visceral Fat, Plasma Leptin, and Plasma Insulin to Youthful Levels. , 1999, Endocrinology.
[132] G. Maestroni,et al. Role of the pineal gland in immunity Circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosterone , 1986, Journal of Neuroimmunology.
[133] C. K. Song,et al. Seasonal Changes in Adiposity: the Roles of the Photoperiod, Melatonin and Other Hormones, and Sympathetic Nervous System , 2002, Experimental biology and medicine.
[134] M. Sjöblom,et al. Peripheral melatonin mediates neural stimulation of duodenal mucosal bicarbonate secretion. , 2001, The Journal of clinical investigation.
[135] S. Cuzzocrea,et al. Melatonin is a scavenger of peroxynitrite. , 1997, Life sciences.
[136] R. Reiter. Oxidative damage in the central nervous system: protection by melatonin , 1998, Progress in Neurobiology.
[137] J. Rosiak,et al. Melatonin as a hydroxyl radical scavenger , 1998, Journal of pineal research.
[138] Vijayalaxmi,et al. A novel melatonin metabolite, cyclic 3-hydroxymelatonin: a biomarker of in vivo hydroxyl radical generation. , 1998, Biochemical and biophysical research communications.
[139] S. Reppert,et al. Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses , 1994, Neuron.
[140] D. Cardinali,et al. Basic aspects of melatonin action. , 1998, Sleep medicine reviews.
[141] T. Fujita,et al. Acute Alteration in Bone Mineral Density and Biochemical Markers for Bone Metabolism in Nephrotic Patients Receiving High-Dose Glucocorticoid and One-Cycle Etidronate Therapy , 2000, Calcified Tissue International.
[142] J. Parkes,et al. Delayed sleep phase syndrome response to melatonin , 1991, The Lancet.
[143] W. Murphy,et al. Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases. , 1985, Arthritis and rheumatism.
[144] J. Gusella,et al. Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[145] T. Annesley,et al. RAPID COMMUNICATION: SERUM IMMUNOREACTIVE MELATONIN IN BOYS WITH DELAYED PUBERTY , 1982, Clinical endocrinology.
[146] B. Vandermeer,et al. Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis , 2006, BMJ : British Medical Journal.
[147] R. Hardeland,et al. Reactions of the melatonin metabolite AMK (N1‐acetyl‐5‐methoxykynuramine) with reactive nitrogen species: Formation of novel compounds, 3‐acetamidomethyl‐6‐methoxycinnolinone and 3‐nitro‐AMK , 2005, Journal of pineal research.
[148] P. Pévet,et al. Contrary to other non-photic cues, acute melatonin injection does not induce immediate changes of clock gene mrna expression in the rat suprachiasmatic nuclei , 2003, Neuroscience.
[149] R. Goodman,et al. Neuroendocrine basis of seasonal reproduction. , 1984, Recent progress in hormone research.
[150] D. Cardinali,et al. Circadian organization of the immune response: A role for melatonin , 2004 .
[151] A. Balík,et al. Melatonin action in neonatal gonadotrophs. , 2004, Physiological research.
[152] G. Brainard,et al. Action Spectrum for Melatonin Regulation in Humans: Evidence for a Novel Circadian Photoreceptor , 2001, The Journal of Neuroscience.
[153] F. Sun,et al. Melatonin protects against MPTP/MPP+‐induced mitochondrial DNA oxidative damage in vivo and in vitro , 2005, Journal of pineal research.
[154] R. Reiter,et al. Identification of melatonin in plants and its effects on plasma melatonin levels and binding to melatonin receptors in vertebrates. , 1995, Biochemistry and molecular biology international.
[155] D. Belsham,et al. Melatonin Receptor Activation Regulates GnRH Gene Expression and Secretion in GT1–7 GnRH Neurons , 2002, The Journal of Biological Chemistry.
[156] L Brydon,et al. Functional expression of MT2 (Mel1b) melatonin receptors in human PAZ6 adipocytes. , 2001, Endocrinology.
[157] R. Wurtman,et al. Improvement of sleep quality by melatonin , 1995, The Lancet.
[158] S. Armstrong. Melatonin and circadian control in mammals , 1989, Experientia.
[159] M. Zembala,et al. Melatonin affords protection against gastric lesions induced by ischemia-reperfusion possibly due to its antioxidant and mucosal microcirculatory effects. , 1997, European journal of pharmacology.
[160] J. L. Esparza,et al. Pro-oxidant activity of aluminum in the rat hippocampus: gene expression of antioxidant enzymes after melatonin administration. , 2005, Free radical biology & medicine.
[161] D. Cardinali,et al. Melatonin in mood disorders , 2006, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[162] Vijayalaxmi,et al. Melatonin: from basic research to cancer treatment clinics. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[163] M. Villareal,et al. Osteoporosis in steroid-dependent asthma. , 1996, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[164] Trevor R. Norman,et al. Acute increases in night-time plasma melatonin levels following a period of meditation , 2000, Biological Psychology.
[165] R. Reiter,et al. Melatonin mitigates mitochondrial malfunction , 2005, Journal of pineal research.
[166] P. Brugger,et al. The roots of meaningful coincidence , 1995, The Lancet.
[167] E. Świętochowska,et al. The relationship between bone metabolism, melatonin and other hormones in sham-operated and pinealectomized rats. , 2003, Endocrine regulations.
[168] S. Carden. Entrainment of Free-running Circadian Rhythms by Melatonin in Blind People, , 2001 .
[169] P. Lavie,et al. Seasonal Variation of Gonadotropins and Gonadal Steroids Receptors in the Human Pineal Gland , 1997, Brain Research Bulletin.
[170] G. Maestroni,et al. Colony-stimulating activity and hematopoietic rescue from cancer chemotherapy compounds are induced by melatonin via endogenous interleukin 4. , 1994, Cancer research.
[171] S. Verlag. Melatonin in elderly patients with insomnia A systematic review , 2001 .
[172] W. Grünberger,et al. A Significant Correlation between Melatonin Deficiency and Endometrial Cancer , 1998, Gynecologic and Obstetric Investigation.
[173] Prahlad T. Ram,et al. Melatonin inhibits estrogen receptor transactivation and cAMP levels in breast cancer cells , 2004, Breast Cancer Research and Treatment.
[174] P. Pévet,et al. The chronobiotic properties of melatonin , 2002, Cell and Tissue Research.
[175] B. Poeggeler,et al. Potent Neuroprotective Properties against the Alzheimer β-Amyloid by an Endogenous Melatonin-related Indole Structure, Indole-3-propionic Acid* , 1999, The Journal of Biological Chemistry.
[176] B. Kos-Kudła,et al. The influence of pinealectomy and melatonin administration on the dynamic pattern of biochemical markers of bone metabolism in experimental osteoporosis in the rat. , 2002, Neuro endocrinology letters.
[177] D. Hakanson,et al. Pineal and Adrenal Effects on Calcium Homeostasis in the Rat , 1990, Pediatric Research.
[178] C. Chignell,et al. Reaction of melatonin and related indoles with hydroxyl radicals: EPR and spin trapping investigations. , 1997, Free radical biology & medicine.
[179] D. Cardinali,et al. Characterization of a cytosol progesterone receptor in bovine pineal gland. , 1979, Neuroendocrinology.
[180] V. Anisimov,et al. Melatonin and colon carcinogenesis. III. Effect of melatonin on proliferative activity and apoptosis in colon mucosa and colon tumors induced by 1,2-dimethylhydrazine in rats. , 2000, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.
[181] O. Vakkuri,et al. Inverse seasonal relationship between melatonin and ovarian activity in humans in a region with a strong seasonal contrast in luminosity. , 1987, The Journal of clinical endocrinology and metabolism.
[182] R. Pomerantz,et al. Reduction of Serum Melatonin Levels in HIV-1-Infected Individuals’ Parallel Disease Progression: Correlation with Serum Interleukin-12 Levels , 2003, Infection.
[183] T. González-Hernández,et al. Estrogen modulation of adrenoceptor responsiveness in the female rat pineal gland: differential expression of intracellular estrogen receptors , 2004, Journal of pineal research.
[184] R. Reiter,et al. An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease , 2000, Journal of Neural Transmission.
[185] S. Takeda,et al. Prednisolone prevents decreases in trabecular bone mass and strength by reducing bone resorption and bone formation defect in adjuvant-induced arthritic rats. , 1998, Bone.
[186] A. Carrillo-Vico,et al. Expression of membrane and nuclear melatonin receptor mRNA and protein in the mouse immune system , 2003, Cellular and Molecular Life Sciences CMLS.
[187] R. Reiter,et al. Melatonin: an antioxidant in edible plants. , 2002, Annals of the New York Academy of Sciences.
[188] J. Vanecek,et al. Melatonin inhibits gonadotropin-releasing hormone-induced elevation of intracellular Ca2+ in neonatal rat pituitary cells. , 1992, Endocrinology.
[189] H. Koyama,et al. Melatonin at Pharmacologic Doses Increases Bone Mass by Suppressing Resorption Through Down‐Regulation of the RANKL‐Mediated Osteoclast Formation and Activation , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[190] F. Hanisch. Specificity Clusters of MUC1-Reactive Mouse Monoclonal Antibodies , 1997, Tumor Biology.
[191] D. Cardinali,et al. Low urinary 6‐sulphatoxymelatonin levels in patients with coronary artery disease , 2000, Journal of pineal research.
[192] R. Turner,et al. Prednisone inhibits formation of cortical bone in sham-operated and ovariectomized female rats , 1995, Calcified Tissue International.
[193] J. Vanecek,et al. Inhibitory effect of melatonin on gonadotropin-releasing hormone-induced Ca2+ oscillations in pituitary cells of newborn rats. , 1997, Neuroendocrinology.
[194] S. J. Mcconnell. The pineal gland and reproduction in the Tammar wallaby, Macropus eugenii , 1984 .
[195] Yukui Zhang,et al. Melatonin in Chinese medicinal herbs. , 2003, Life sciences.
[196] P. Lavie,et al. ACTIGRAPHIC SLEEP-WAKE PATTERNS AND URINARY 6-SULFATOXYMELATONIN EXCRETION IN PATIENTS WITH ALZHEIMER'S DISEASE , 2001, Chronobiology international.
[197] R. Haque,et al. Circadian clocks, clock networks, arylalkylamine N-acetyltransferase, and melatonin in the retina , 2005, Progress in Retinal and Eye Research.
[198] M. Okawa,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Diminished Melatonin Secretion in the Elderly Caused by Insufficient Environmental Illumination* , 2022 .
[199] R. Reiter,et al. Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. , 2002, Current topics in medicinal chemistry.
[200] R. Reiter,et al. Melatonin‐induced increased activity of the respiratory chain complexes I and IV can prevent mitochondrial damage induced by ruthenium red in vivo , 2000, Journal of pineal research.
[201] D. Berson,et al. Phototransduction by Retinal Ganglion Cells That Set the Circadian Clock , 2002, Science.
[202] L. Wetterberg,et al. Nocturnal melatonin secretion in thyroid disease and in obesity , 1991, Clinical endocrinology.
[203] D. Acuña-Castroviejo,et al. Mitochondrial regulation by melatonin and its metabolites. , 2003, Advances in experimental medicine and biology.
[204] G. Brown,et al. Relationship between melatonin levels in plasma and gastrointestinal tissues and the incidence and severity of gastric ulcers in pigs , 1998, Journal of pineal research.
[205] D. Tobin,et al. The cutaneous serotoninergic/melatoninergic system: securing a place under the sun , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[206] R. Hardeland,et al. Circadian Rhythms, Oxidative Stress, and Antioxidative Defense Mechanisms , 2003, Chronobiology international.
[207] D. Cardinali,et al. Melatonin effects on bone: experimental facts and clinical perspectives , 2003, Journal of pineal research.
[208] D. Cardinali,et al. Lack of changes in serum prolactin, FSH, TSH, and estradiol after melatonin treatment in doses that improve sleep and reduce benzodiazepine consumption in sleep‐disturbed, middle‐aged, and elderly patients , 2001, Journal of pineal research.
[209] S. Armstrong,et al. Chronobiotics--drugs that shift rhythms. , 1996, Pharmacology & therapeutics.
[210] S. Berga,et al. Amplification of nocturnal melatonin secretion in women with functional hypothalamic amenorrhea. , 1988, The Journal of clinical endocrinology and metabolism.
[211] T. Mukherjee,et al. Antioxidant properties of melatonin: a pulse radiolysis study. , 1999, Free radical biology & medicine.
[212] L. Grunhaus,et al. Melatonin for the treatment of sleep disturbances in major depressive disorder. , 1998, The American journal of psychiatry.
[213] I. Sayeed,et al. Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism responsible for anti‐apoptotic effects of melatonin , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[214] N. Gjerdet,et al. Pinealectomy induces malformation of the spine and reduces the mechanical strength of the vertebrae in Atlantic salmon, Salmo salar , 2004, Journal of pineal research.
[215] J. B. Martin,et al. Molecular basis of the neurodegenerative disorders. , 1999, The New England journal of medicine.
[216] Bruno Claustrat,et al. The basic physiology and pathophysiology of melatonin. , 2005, Sleep medicine reviews.
[217] V. Anisimov. Effects of Exogenous Melatonin—A Review , 2003, Toxicologic pathology.
[218] H. Bartsch,et al. Melatonin in cancer patients and in tumor-bearing animals. , 1999, Advances in experimental medicine and biology.
[219] B Frangione,et al. Melatonin reverses the profibrillogenic activity of apolipoprotein E4 on the Alzheimer amyloid Abeta peptide. , 2001, Biochemistry.
[220] Irina Zhdanova,et al. Effects of exogenous melatonin on sleep: a meta-analysis. , 2005, Sleep medicine reviews.
[221] H. Iguichi,et al. Age-dependent reduction in serum melatonin concentrations in healthy human subjects. , 1982, The Journal of clinical endocrinology and metabolism.
[222] G. Kerkhof,et al. Delayed sleep phase syndrome: A placebo‐controlled cross‐over study on the effects of melatonin administered five hours before the individual dim light melatonin onset , 1998, Journal of sleep research.
[223] F. Herrera,et al. Melatonin regulation of antioxidant enzyme gene expression , 2002, Cellular and Molecular Life Sciences CMLS.
[224] M. Dubocovich,et al. Functional MT1 and MT2 melatonin receptors in mammals , 2005, Endocrine.
[225] G. Ferry,et al. Molecular evidence that melatonin is enzymatically oxidized in a different manner than tryptophan: investigations with both indoleamine 2,3-dioxygenase and myeloperoxidase. , 2005, The Biochemical journal.
[226] B. Kos-Kudła,et al. Influence of lighting conditions on daily rhythm of bone metabolism in rats and possible involvement of melatonin and other hormones in this process. , 2003, Endocrine regulations.
[227] M. Dubocovich,et al. Functional Melatonin Receptors in Rat Ovaries at Various Stages of the Estrous Cycle , 2003, Journal of Pharmacology and Experimental Therapeutics.
[228] L. Wetterberg,et al. Melatonin production in patients with duodenal ulcer. , 2001, Neuro endocrinology letters.
[229] C. Guilleminault,et al. Rapid shift in peak melatonin secretion associated with improved performance in short shift work schedule. , 1997, Sleep.
[230] M. Herold,et al. Impaired nocturnal secretion of melatonin in coronary heart disease , 1995, The Lancet.
[231] Josep M. Guerrero,et al. Melatonin enhances IL-2, IL-6, and IFN-gamma production by human circulating CD4+ cells: a possible nuclear receptor-mediated mechanism involving T helper type 1 lymphocytes and monocytes. , 1997, Journal of immunology.
[232] Prahlad T. Ram,et al. Melatonin synergizes with retinoic acid in the prevention and regression of breast cancer. , 1999, Advances in experimental medicine and biology.
[233] M. Turgut,et al. Morphological, stereological and radiological changes in pinealectomized chicken cervical vertebrae , 2005, Journal of pineal research.
[234] H. Wong,et al. Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: role of inhibition of NFκB activation , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[235] A. Lewy,et al. Sleep-promoting effects of melatonin: at what dose, in whom, under what conditions, and by what mechanisms? , 1997, Sleep.
[236] D. Garfinkel,et al. Melatonin for treatment of sundowning in elderly persons with dementia - a preliminary study. , 2000, Archives of gerontology and geriatrics.
[237] R. Reiter,et al. Melatonin—A Highly Potent Endogenous Radical Scavenger and Electron Donor: New Aspects of the Oxidation Chemistry of this Indole Accessed in vitro a , 1994, Annals of the New York Academy of Sciences.
[238] H. Korf,et al. The rhythm and blues of gene expression in the rodent pineal gland , 2005, Endocrine.
[239] D. Acuña-Castroviejo,et al. Melatonin increases the activity of the oxidative phosphorylation enzymes and the production of ATP in rat brain and liver mitochondria. , 2002, The international journal of biochemistry & cell biology.
[240] A. Strosberg,et al. Functional Expression of MT 2 ( Mel 1 b ) Melatonin Receptors in Human PAZ 6 Adipocytes , 2001 .
[241] A. Dosé,et al. Melatonin's unique radical scavenging properties – roles of its functional substituents as revealed by a comparison with its structural analogs , 2002, Journal of pineal research.
[242] J. A. Boer,et al. Clinical efficacy of agomelatine in depression: the evidence , 2005 .
[243] V. Srinivasan,et al. Melatonin, immune function and aging , 2005, Immunity & Ageing.
[244] P. Renard,et al. Melatonin reduces body weight gain in Sprague Dawley rats with diet-induced obesity. , 2003, Endocrinology.
[245] J. Hébert,et al. Meditation, melatonin and breast/prostate cancer: hypothesis and preliminary data. , 1995, Medical hypotheses.
[246] Benita Middleton,et al. Melatonin advances the circadian timing of EEG sleep and directly facilitates sleep without altering its duration in extended sleep opportunities in humans , 2004, The Journal of physiology.
[247] P. Good,et al. Unusual degradation of α-β complexes in Xenopus oocytes by β-subunits of Xenopus gastric H-K-ATPase. , 1998, American journal of physiology. Cell physiology.
[248] S. Rozov,et al. N1‐acetyl‐N2‐formyl‐5‐methoxykynuramine is a product of melatonin oxidation in rats , 2003, Journal of pineal research.
[249] R. Reiter,et al. Melatonin-immune system relationships. , 2002, Current topics in medicinal chemistry.
[250] D. Skene,et al. Melatonin administration can entrain the free-running circadian system of blind subjects. , 2000, The Journal of endocrinology.
[251] R. Hardeland,et al. Reactions of the melatonin metabolite N1-acetyl-5-methoxykynuramine (AMK) with the ABTS cation radical: identification of new oxidation products. , 2006, Redox report : communications in free radical research.
[252] S. Folkard,et al. Some effects of melatonin and the control of its secretion in humans. , 2008, Ciba Foundation symposium.
[253] D. Tobin,et al. On the role of melatonin in skin physiology and pathology , 2005, Endocrine.
[254] R. Reiter,et al. Melatonin: a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin , 2003, Journal of pineal research.
[255] M. Dubocovich,et al. Melatonin mediates two distinct responses in vascular smooth muscle. , 1998, European journal of pharmacology.
[256] G. Benítez-King. Melatonin as a cytoskeletal modulator: implications for cell physiology and disease , 2006, Journal of pineal research.
[257] R. Moore,et al. Circadian rhythms: basic neurobiology and clinical applications. , 1997, Annual review of medicine.
[258] Josep M. Guerrero,et al. Reactive Oxygen Intermediates, Molecular Damage, and Aging: Relation to Melatonin , 1998, Annals of the New York Academy of Sciences.
[259] J. Commentz,et al. Precocious puberty and decreased melatonin secretion due to a hypothalamic hamartoma. , 1995, Hormone research.
[260] D. Cardinali,et al. The Use of Chronobiotics in the Resynchronization of the Sleep–wake Cycle , 2006, Cancer Causes & Control.
[261] Cristina Bianchi,et al. The Mitochondrial Production of Reactive Oxygen Species in Relation to Aging and Pathology , 2004, Annals of the New York Academy of Sciences.
[262] N. Zisapel,et al. Melatonin receptors in PC3 human prostate tumor cells , 1999, Journal of pineal research.
[263] Josephine Arendt,et al. Melatonin as a chronobiotic. , 2005, Sleep medicine reviews.
[264] H. Koyama,et al. Melatonin stimulates proliferation and type I collagen synthesis in human bone cells in vitro , 1999, Journal of pineal research.
[265] D. Cardinali,et al. Melatonin effect on bone metabolism in rats treated with methylprednisolone , 2006, Journal of pineal research.
[266] V. Gribkoff,et al. Molecular Dissection of Two Distinct Actions of Melatonin on the Suprachiasmatic Circadian Clock , 1997, Neuron.
[267] D. Saur,et al. Melatonin reduces non‐adrenergic, non‐cholinergic relaxant neurotransmission by inhibition of nitric oxide synthase activity in the gastrointestinal tract of rodents in vitro , 2002, Journal of pineal research.
[268] M. Candito,et al. Circadian rhythms in depression and recovery: Evidence for blunted amplitude as the main chronobiological abnormality , 1989, Psychiatry Research.
[269] R. Liburdy,et al. Melatonin and its precursors scavenge nitric oxide , 1999, Journal of pineal research.
[270] F. Hirata,et al. In vitro and in vivo formation of two new metabolites of melatonin. , 1974, The Journal of biological chemistry.
[271] A. Cagnacci,et al. Influences of melatonin administration on the circulation of women. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.
[272] D. Pozo,et al. Melatonin activates Th1 lymphocytes by increasing IL-12 production. , 1999, Life sciences.
[273] D. Cardinali,et al. Monozygotic twins with Alzheimer's disease treated with melatonin: Case report , 1998, Journal of pineal research.
[274] I. Zhdanova,et al. Melatonin as a hypnotic: pro. , 2005, Sleep medicine reviews.
[275] N. Zisapel,et al. Circadian Rhythm Sleep Disorders , 2001, CNS drugs.
[276] C. Carlberg,et al. Transcriptional activation of the nuclear receptor RZR alpha by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand. , 1995, Nucleic acids research.
[277] D. Cardinali,et al. Effect of Melatonin Treatment on 24‐h Variations in Responses to Mitogens and Lymphocyte Subset Populations in Rat Submaxillary Lymph Nodes , 2000, Journal of neuroendocrinology.
[278] D. Cardinali,et al. Low urinary 6-sulfatoxymelatonin levels in patients with severe congestive heart failure , 2003, Endocrine.
[279] B. Griefahn,et al. Excretion of 6-Hydroxymelatonin Sulfate (6-OHMS) in Siblings during Childhood and Adolescence , 2003, Neuroendocrinology.
[280] P. Lissoni,et al. Five years survival in metastatic non‐small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial , 2003, Journal of pineal research.
[281] Ichiro Baba,et al. Implication for Melatonin and Its Receptor in the Spinal Deformities of Hereditary Lordoscoliotic Rabbits , 2003, Spine.
[282] D. Pompon,et al. Nitrosation of melatonin by nitric oxide and peroxynitrite , 2000, Journal of pineal research.